The China plus one strategy encourages diversification of suppliers due to geopolitical risks, which benefits Indian companies across various sectors. In pharma, both traditional and CDMO segments show opportunities. The industrial sector grows more attractive as interest rates drop and currency stabilizes. The strategy also provides a competitive edge to Indian exporters facing Chinese competition.
RR Kabel shares jump 10% as Q1 PAT surges 129% YoY, Ebitda doubles
RR Kabel reported a strong June-quarter performance, with profit after tax surging 129% year-on-year and Ebitda nearly doubling, driven by robust growth in its Wires
July 28, 2026